z-logo
open-access-imgOpen Access
Serum Fibrinopeptide A is increased in patients with Acute Coronary Syndrome
Author(s) -
hmet Seyda Yilmaz
Publication year - 2021
Publication title -
i̇stanbul kuzey klinikleri
Language(s) - English
Resource type - Journals
ISSN - 2148-4902
DOI - 10.14744/nci.2021.12499
Subject(s) - medicine , acute coronary syndrome , cardiology , coagulative necrosis , antithrombotic , thrombus , myocardial infarction , coronary artery disease , gastroenterology
Acute coronary syndrome (ACS) is one of the leading causes of mortality, globally. Atherosclerosis is an underlying factor in ACS process and coagulative cascade is activated secondary to atherosclerotic plaque rupture. Fibrinopeptide A (FPA) takes an active role in thrombus formation and is an indicator of coagulative process. We aimed to evaluate serum FPA level in patients with ACS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here